ArticleProstate cancer and prostatic diseases2022

Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer.

Jiun-Hung Geng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.